The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease
Abstract
Background: In Alzheimer’s disease (AD), it is unknown whether the brain can utilize additional ketones as fuel when they are derived from a medium chain triglyceride (MCT) supplement. Objective: To assess whether brain ketone uptake in AD increases in response to MCT as it would in young healthy adults. Methods: Mild-moderate AD patients sequentially consumed 30 g/d of two different MCT supplements, both for one month: a mixture of caprylic (55%) and capric acids (35%) (n = 11), followed by a wash-out and then tricaprylin (95%; n = 6). Brain ketone (11C-acetoacetate) and glucose (FDG) uptake were quantified by PET before and after each MCT intervention. Results: Brain ketone consumption doubled on both types of MCT supplement. The slope of the relationship between plasma ketones and brain ketone uptake was the same as in healthy young adults. Both types of MCT increased total brain energy metabolism by increasing ketone supply without affecting brain glucose utilization. Conclusion: Ketones from MCT compensate for the brain glucose deficit in AD in direct proportion to the level of plasma ketones achieved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike glucose metabolism, ketone metabolism does not appear to be altered in the early progression of AD, as ketones are used at the same rate in MCI and early AD as in the control brain [122,123].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [123]
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Alsop, D. C., Detre, J. A., Golay, X., Günther, M., Hendrikse, J., Hernandez‐Garcia, L., Lu, H., MacIntosh, B. J., Parkes, L. M., Smits, M., et al. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25197 · Cited by 2,206
REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing
Song, X.-W., Dong, Z.-Y., Long, X.-Y., Li, S.-F., Zuo, X.-N., Zhu, C.-Z., He, Y., Yan, C.-G., & Zang, Y.-F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025031 · Cited by 1,872
Müller-Gärtner, H. W., Links, J. M., Prince, J. L., Bryan, R. N., McVeigh, E., Leal, J. P., Davatzikos, C., & Frost, J. J. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.81 · Cited by 756
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2011) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 614
Self-citationBrain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Mosconi, L., Pupi, A., & De Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 595
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548
Effects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia
Du, A.-T., Schuff, N., Kramer, J. H., Rosen, H. J., Gorno-Tempini, M. L., Rankin, K., Miller, B. L., & Weiner, M. W. (2006) · Brain · doi:10.1093/brain/awm016 · Cited by 482
Graphical analysis of PET data applied to reversible and irreversible tracers
Logan, J. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00137-2 · Cited by 416
Cited by
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Self-citationEffects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment
Fortier, M., Castellano, C., Croteau, E., Langlois, F., Bocti, C., St‐Pierre, V., Vandenberghe, C., Bernier, M., Roy, M., Descoteaux, M., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.12.017 · Cited by 216
Self-citationThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT
Fortier, M., Castellano, C., St‐Pierre, V., Myette‐Côté, É., Langlois, F., Roy, M., Morin, M., Bocti, C., Fulop, T., Godin, J., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12206 · Cited by 187
Self-citation
Metadata
- Authors
- Croteau, E., Castellano, C.-A., Richard, M. A., Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., Fülöp, T., & Cunnane, S. C.
- Affiliations
- Research Center on Aging, Université de Sherbrooke, Sherbrooke, QC, Canada
- Université de Sherbrooke (CA)
- Institut Universitaire en Santé Mentale de Québec (CA)
- Corresponding author
- Cunnane, Stephen C.
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2018-06-19
- Volume
- 64
- Issue
- 2
- Pages
- 551-561
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2808219686
- Cited by
- 135
- References
- 37
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 20 · 2023: 19 · 2022: 16 · 2021: 19 · 2020: 30 · 2019: 10 · 2018: 3
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, medium-chain triglycerides
- MeSH terms
- Acetates, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Carbon, Energy Metabolism, Female, Humans, Ketones, Magnetic Resonance Imaging, Male, Triglycerides, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease. https://app.cochat.ai/papers/10.3233/jad-180202
- The paper
- Croteau, E., Castellano, C.-A., Richard, M. A., Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., Fülöp, T., & Cunnane, S. C. (2018). Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-180202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.